Splice variants of RAS-translational significance
- PMID: 32772213
- PMCID: PMC7680328
- DOI: 10.1007/s10555-020-09920-8
Splice variants of RAS-translational significance
Abstract
One of the mechanisms potentially explaining the discrepancy between the number of human genes and the functional complexity of organisms is generating alternative splice variants, an attribute of the vast majority of multi-exon genes. Members of the RAS family, such as NRAS, KRAS and HRAS, all of which are of significant importance in cancer biology, are no exception. The structural and functional differences of these splice variants, particularly if they contain the canonical (and therefore routinely targeted for diagnostic purposes) hot spot mutations, pose a significant challenge for targeted therapies. We must therefore consider whether these alternative splice variants constitute a minor component as originally thought and how therapies targeting the canonical isoforms affect these alternative splice variants and their overall functions.
Keywords: Expression; Function; HRAS; KRAS; NRAS; Splicing.
Figures
![Fig. 1](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a434/7680328/451aa21444ff/10555_2020_9920_Fig1_HTML.gif)
![Fig. 2](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a434/7680328/8740cddd4ca3/10555_2020_9920_Fig2_HTML.gif)
![Fig. 3](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a434/7680328/ba96225bdc90/10555_2020_9920_Fig3_HTML.gif)
![Fig. 4](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a434/7680328/331cceaa90e7/10555_2020_9920_Fig4_HTML.gif)
Similar articles
-
Differential functions of the KRAS splice variants.Biochem Soc Trans. 2023 Jun 28;51(3):1191-1199. doi: 10.1042/BST20221347. Biochem Soc Trans. 2023. PMID: 37222266 Free PMC article. Review.
-
Silent mutations reveal therapeutic vulnerability in RAS Q61 cancers.Nature. 2022 Mar;603(7900):335-342. doi: 10.1038/s41586-022-04451-4. Epub 2022 Mar 2. Nature. 2022. PMID: 35236983
-
Oncogenic KRAS alters splicing factor phosphorylation and alternative splicing in lung cancer.BMC Cancer. 2022 Dec 16;22(1):1315. doi: 10.1186/s12885-022-10311-1. BMC Cancer. 2022. PMID: 36522653 Free PMC article.
-
Origin and Evolution of RAS Membrane Targeting.Oncogene. 2023 May;42(21):1741-1750. doi: 10.1038/s41388-023-02672-z. Epub 2023 Apr 8. Oncogene. 2023. PMID: 37031342 Free PMC article.
-
K-Ras prenylation as a potential anticancer target.Cancer Metastasis Rev. 2020 Dec;39(4):1127-1141. doi: 10.1007/s10555-020-09902-w. Cancer Metastasis Rev. 2020. PMID: 32524209 Free PMC article. Review.
Cited by
-
Targeted therapies for KRAS-mutant non-small cell lung cancer: from preclinical studies to clinical development-a narrative review.Transl Lung Cancer Res. 2023 Feb 28;12(2):346-368. doi: 10.21037/tlcr-22-639. Epub 2023 Feb 20. Transl Lung Cancer Res. 2023. PMID: 36895930 Free PMC article. Review.
-
Targeting KRAS in Pancreatic Ductal Adenocarcinoma: The Long Road to Cure.Cancers (Basel). 2023 Oct 17;15(20):5015. doi: 10.3390/cancers15205015. Cancers (Basel). 2023. PMID: 37894382 Free PMC article. Review.
-
KRAS and MET in non-small-cell lung cancer: two of the new kids on the 'drivers' block.Ther Adv Respir Dis. 2022 Jan-Dec;16:17534666211066064. doi: 10.1177/17534666211066064. Ther Adv Respir Dis. 2022. PMID: 35098800 Free PMC article. Review.
-
Roles and mechanisms of aberrant alternative splicing in melanoma - implications for targeted therapy and immunotherapy resistance.Cancer Cell Int. 2024 Mar 10;24(1):101. doi: 10.1186/s12935-024-03280-x. Cancer Cell Int. 2024. PMID: 38462618 Free PMC article. Review.
-
The complex, dynamic SpliceOme of the small GTPase transcripts altered by technique, sex, genetics, tissue specificity, and RNA base editing.Front Cell Dev Biol. 2022 Nov 17;10:1033695. doi: 10.3389/fcell.2022.1033695. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 36467401 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous